-
Single-cell RNA-sequencing of a multi-region pleural mesothelioma case
Study
EGAS00001008062
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_ATAC
Study
EGAS00001008083
-
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
Study
EGAS00001008140
-
Cross-species Comparison Reveals Therapeutic Vulnerabilities Halting Glioblastoma Progression
Study
EGAS00001008155
-
Analysis of enhancer-promoter connectivity alterations
Study
EGAS00001007411
-
Integrative Multi-Omics and Drug Sensitivity Profiling Reveals Potential Predictive Biomarkers in Pediatric Solid Tumors from the INFORM Registry
Study
EGAS00001008249
-
Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options; a feasibility study
Study
EGAS50000001583
-
Co-culture experiment (hashed samples)
Study
EGAS50000001252
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505
-
IMMUcan SCCHN1 cohort
Study
EGAS50000001533
-
MorphoITH: A Framework for Deconvolving Intra-Tumor Heterogeneity Using Tissue Morphology
Study
EGAS50000001064
-
MutWP1__CRUK_Grand_Challenge__normal_kidney_Nanoseq
Study
EGAS00001005451
-
PDX_models_from_Latin_America_WES_
Study
EGAS00001005663
-
MutWP1__CRUK_Grand_Challenge__matched_blood_Nanoseq
Study
EGAS00001006774
-
Lymphoma_WGS
Study
EGAS00001007653
-
MPN_Tissue_WGS_NanoSeq
Study
EGAS00001007761
-
PDX_models_from_Latin_America_RNAseq
Study
EGAS00001008150
-
PDX_models_from_Latin_America_Xenofiltered_WES
Study
EGAS00001008231
-
PDX_models_from_Latin_America_RNAseq_Xenofiltered
Study
EGAS00001008232
-
CRISPR_Screening_of_Brazilian_Acral_Melanoma_Cell_Lines
Study
EGAS00001008230
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Transcriptomic profiling of circulating regulatory T cells from follicular lymphoma patients before and after Lenalidomide treatment
Study
EGAS50000001048
-
A prospective multicenter study of plasma ctDNA versus archival tumor tissue to guide FGFR-targeted therapy in metastatic urothelial cancer - Targeted
Study
EGAS50000001450
-
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Study
EGAS00001002606
-
Spatial Transcriptomic data from Invasive lobular breast carcinoma (ILC)
Study
EGAS50000001735
-
Transcriptome analysis of soft tissue sarcoma
Study
EGAS50000001672
-
Whole exome sequencing of soft tissue sarcoma
Study
EGAS50000001673
-
Genomic and transcriptomic profiling of soft tissue sarcoma
Dataset
EGAD50000000846
-
Development and first-in-human CAR T therapy targeting the pathognomonic MiT-fusion driven protein GPNMB
Study
EGAS50000001696
-
ASPSCR1-TFE3 gene fusion panel deep amplicon sequencing data
Dataset
EGAD50000002438
-
Circulating kidney injury molecule-1 (KIM-1) and association with response to adjuvant immunotherapy in renal cell carcinoma
Study
EGAS50000001285
-
Genomic and clinical data from IMmotion010, a phase 3 randomised clinical trial testing adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection
Dataset
EGAD50000001827
-
Recurrent/Metastatic Adenoid Cystic Carcinoma Treated with Axitinib and Avelumab
Study
EGAS50000001714
-
WES of Adenoid Cystic Carcinoma Treated with Axitinib and Avelumab
Dataset
EGAD50000002467
-
miRNA-seq of paired Follicular Lymphoma (FL) patient samples before and after high-grade transformation to DLBCL (FL vs. tFL) from FFPE tissues
Study
EGAS50000000942
-
mRNA-seq of paired Follicular Lymphoma (FL) patient samples before and after high-grade transformation to DLBCL (FL vs. tFL) from FFPE tissues
Study
EGAS50000000941
-
Methylation Biomarkers can Distinguish Pleural Mesothelioma from Healthy Pleura and other Pleural Pathologies
Study
EGAS00001008153
-
Orphan_Tumour_Study___familial_neuroblastoma
Study
EGAS00001002171
-
Somatic L1 retrotransposition dynamics in high-grade serous ovarian cancer
Study
EGAS50000001198
-
Single Cell RNA Transcriptomics of Mantle Cell Lymphoma Reveals the Presence of Treatment-Resistant Subclones at the Time of Diagnosis
Study
EGAS50000000825
-
scRNA-seq of LN and lymphoma stroma
Study
EGAS00001005732
-
A conserved enhancer in ecDNA-containing Medulloblastoma
Study
EGAS50000001609
-
A conserved enhancer in ecDNA-containing Medulloblastoma
Study
EGAS50000001608
-
A conserved enhancer in ecDNA-containing Medulloblastoma
Study
EGAS50000001610
-
CUT&RUN in G3-MB
Dataset
EGAD50000002301
-
G3-MB WGS
Dataset
EGAD50000002302
-
ChIP-seq for G3-MB
Dataset
EGAD50000002303
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Study
EGAS00001003931
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH
Study
EGAS00001004285
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma
Study
EGAS00001005356
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma
Study
EGAS00001006986
-
Multi-organ landscape of therapy-resistant melanoma
Study
EGAS00001006644
-
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas: Somatic exome variants
Dataset
EGAD00001002650
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
NanoString nCounter® PanCancer IO 360™on anti-PD1/anti-PD1+CTLA4 in patients with metastatic melanoma
Study
EGAS00001006977
-
DLP+ Single Cell Genomic Library A98288
Dataset
EGAD00001010247
-
An IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma
Study
EGAS00001007038
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
10X 3' V2 data of single immune cells in hepatocellular carcinoma
Dataset
EGAD00001005961
-
MCL NGS data
Dataset
EGAD00001006025
-
Sequencing data for oesophageal and related samples - Mourikis et al (RNA)
Dataset
EGAD00001004776
-
Genome and transcriptome sequence data from a breast ductal carcinoma patient
Dataset
EGAD00001002047
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Dataset
EGAD00001005495
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005901
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma -- CA209-010
Dataset
EGAD00001006026
-
MutWP1: CRUK Grand Challenge Mutographs of Cancer: Colorectal_LCM (2020-02-20)
Dataset
EGAD00001005994
-
Genome and transcriptome sequence data from a retroperitoneal leiomyosarcoma patient
Dataset
EGAD00001002583
-
MutWP1: CRUK Grand Challenge Mutographs of Cancer: Oesophageal adenocarcinoma
Dataset
EGAD00001006083
-
Competitive selection of somatic mutant clones in normal human skin varies with body site
Dataset
EGAD00001006194
-
Genome and transcriptome sequence data from a diffuse large B-cell lymphoma patient
Dataset
EGAD00001004906
-
Whole-exome sequencing laser capture micro-dissected biopsies of human renal cell carcinoma
Dataset
EGAD00001008029
-
Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient
Dataset
EGAD00001003665
-
BLUEPRINT release August 2016, Bisulfite-Seq for Mantle Cell Lymphoma, on genome GRCh38
Dataset
EGAD00001002505
-
Esophageal adenocarcinoma plasma cfDNA samples - PERFECT cohort and nCRT cohort
Dataset
EGAD00001008316
-
Genome and transcriptome sequence data from a ductal carcinoma of left breast patient
Dataset
EGAD00001002574
-
Genome and transcriptome sequence data from an adenocarcinoma of primary unknown cancer patient
Dataset
EGAD00001002577
-
Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma patient
Dataset
EGAD00001002589
-
Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma
Dataset
EGAD00001006151
-
Amplicon sequencing of adenoma to carcinoma paired samples from colon
Dataset
EGAD00001004848
-
Preferential infiltration of unique Vγ9Jγ2‐Vδ2 T cells into glioblastoma multiforme
Dataset
EGAD00001004862
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Dataset
EGAD00001006287
-
Strand-specific RNA Sequencing of initial and recurrent gliomas
Dataset
EGAD00001003764
-
Melanoma transcriptome profiling
Dataset
EGAD00001006270